The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

BioAmber Inc

NYSE: BIOA
Last

(U.S.) $3.73

Today's change-0.25 -6.28%
Updated February 5 4:02 PM EST. Delayed by at least 15 minutes.
 

BioAmber Inc

NYSE: BIOA
Last

(U.S.) $3.73

Today's change-0.25 -6.28%
Updated February 5 4:02 PM EST. Delayed by at least 15 minutes.

BioAmber Inc down (U.S.)$0.25

BioAmber Inc closed sharply lower Friday, dropping (U.S.)$0.25 or 6.28% to (U.S.)$3.73. Over the last five days, shares have lost 6.98% and are down 39.64% for the last year to date. This security has underperformed the S&P 500 by 50.30% during the last year.

Key company metrics

  • Open(U.S.) $3.90
  • Previous close(U.S.) $3.98
  • High(U.S.) $3.97
  • Low(U.S.) $3.70
  • Bid / Ask-- / --
  • YTD % change-39.64%
  • Volume32,943
  • Average volume (10-day)44,042
  • Average volume (1-month)74,655
  • Average volume (3-month)75,342
  • 52-week range(U.S.) $3.50 to (U.S.) $11.30
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.37
Updated February 5 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-2,705.90%

BioAmber Inc has a net profit margin of -2,705.90%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.08%Sector:Basic MaterialsIndustry:Chemicals - Specialty

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit000-2
Total cost of revenue0102
Total operating expense1011910
Selling / general / administrative3443
Research & development6554
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)01--1
Other operating expenses, total--------
Operating income-10-11-8-10
Interest income (expense), net non-operating-1-100
Gain (loss) on sale of assets--------
Other--------
Income before tax-8-15-9-5
Income after tax-8-15-9-5
Income tax, total0000
Net income-7-14-8-4
Total adjustments to net income--------
Net income before extra. items-7-14-8-4
Minority interest1110
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-7-14-8-4
Inc. avail. to common incl. extra. items-7-14-8-4
Diluted net income-7-14-8-4
Dilution adjustment------0
Diluted weighted average shares26242222
Diluted EPS excluding extraordinary itemsvalue per share-0.27-0.58-0.38-0.20
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.27-0.55-0.38-0.18